Johnson & Johnson offered $8.9 billion to settle years-old lawsuits claiming that its talcum powder products caused cancer.
The New Jersey-based pharmaceutical giant described their proposal, which still needs a bankruptcy court’s approval, as an equitable and efficient resolution to all claims arising from cosmetic talc litigation.
If approved by the bankruptcy court and a majority of the claimants, the $8.9 billion deal would rank alongside those reached by cigarette corporations and opioid producers as one of the largest product liability settlements ever in the US
Thousands of claims have been filed against J&J because of talcum powder that may have contained traces of asbestos and was linked to ovarian cancer.
The company has never acknowledged wrongdoing, but as of May 2020, it no longer sells its talc-based baby powder in the US and Canada.
The $8.9 billion would be paid to the tens of thousands of claimants over 25 years through a J&J subsidiary, LTL Management LLC, which was set up to address the claims and has filed for bankruptcy protection.
A previous settlement involving LTL was rejected by an appellate court.


Google Halts UK YouTube TV Measurement Service After Legal Action
Instagram Outage Disrupts Thousands of U.S. Users
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target
Oil Prices Slip as U.S.–Iran Talks Ease Supply Disruption Fears
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment
CK Hutchison Unit Launches Arbitration Against Panama Over Port Concessions Ruling
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Federal Reserve Faces Subpoena Delay Amid Investigation Into Chair Jerome Powell
Dollar Near Two-Week High as Stock Rout, AI Concerns and Global Events Drive Market Volatility
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 



